Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-27

Clinical Trial Update: An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency [NA]

View source ↗

Summary

Clinical trial evaluation of Proglucamune for Protective Qi Insufficiency has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proglucamune (Proglucamune)

Snippet

Sponsor: USANA Health Sciences | Conditions: Protective Qi Insufficiency | NA | Status: COMPLETED | Results posted: 2021-10-27